Open Accessibility Menu

No Antidote for Bleeding Makes Pradaxa a 'Truly Defective Drug'

The Law Offices of Tyler & Peery

As Jef Feeley and Margaret Cronin Fisk report for Bloomberg Businessweek, hundreds of patients who suffered bad side effects from taking Pradaxa to prevent a stroke have sued drug maker Boehringer Ingelheim, which has made more than $1 billion in sales off Pradaxa since bringing the drug to market.

Pradaxa has been marketed as a safe alternative to Coumadin, a blood thinner that the FDA approved for use decades ago. The generic name for the drug Coumadin is "warfarin," which was approved back in 1954.

Yet, at this time, there is no way to reverse bleeding for patients on Pradaxa as compared to patients on Coumadin, prompting one attorney representing injured patients and their families to say that Pradaxa is a "truly defective drug," as Feeley and Fisk report.

It's defective because there's no antidote. Bleeding, in turn, can become uncontrollable and lead to a patient's death.

There are cases pending against Boehringer Ingelheim in state and federal courts across the country.

Source: Boehringer Sued by Hundreds Over Bleeding Tied to Pradaxa


Request Your
Free Consultation

  • Please enter your first name.
  • Please enter your last name.
  • This isn't a valid phone number.
    Please enter your phone number.
    You entered an invalid number.
  • This isn't a valid email address.
    Please enter your email address.
  • Please make a selection.
  • Please enter a message.
Why Choose Our Firm?
  • 100+ Years of Combined Experience
  • You Don’t Pay Unless We Win
  • Home & Hospital Visits Available
  • Millions of Dollars Recovered
  • Se Habla Español